Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Gravalos, C; Rodriguez, C; Sabino, A; Segui, MA; Virizuela, JA; Carmona, A; Cassinello, J; Isla, D; Jara, C; Martin, M.

SEOM Clinical Guideline for bone metastases from solid tumours (2016)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2016; 18(12): 1243-1253 Nº de citas: 24 [doi:10.1007/s12094-016-1590-1]

de las Penas, R; Blasco, A; De Castro, J; Escobar, Y; Garcia-Campelo, R; Gurpide, A; Lopez-Lopez, R; Majem, M; Rodriguez, CA; Virizuela, JA.

SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2016; 18(12): 1237-1242 Nº de citas: 11 [doi:10.1007/s12094-016-1583-0]

Lopez-Pousa, A; Broto, JM; Trufero, JM; Sevilla, I; Valverde, C; Alvarez, R; Alvarez, JAC; Jurado, JC; Hindi, N; del Muro, XG.

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2016; 18(12): 1213-1220 Nº de citas: 27 [doi:10.1007/s12094-016-1574-1]

Garcia, KF; Ridruejo, JS; Olbes, PR; Molina, MSL; Arias, MIA.

Therapeutic attitude towards internal mammary chain drainage in patients with breast cancer

BREAST. 2016; 30: 1-4 Nº de citas: 6 [doi:10.1016/j.breast.2016.08.001]

Finn, RS; Martin, M; Rugo, HS; Jones, S; Im, SA; Gelmon, K; Harbeck, N; Lipatov, ON; Walshe, JM; Moulder, S; Gauthier, E; Lu, DRR; Randolph, S; Dieras, V; Slamon, DJ.

Palbociclib and Letrozole in Advanced Breast Cancer

NEW ENGLAND JOURNAL OF MEDICINE. 2016; 375(20): 1925-1936 Nº de citas: 2284 [doi:10.1056/NEJMoa1607303]

Garcia-Alfonso, P; Feliu, J; Garcia-Carbonero, R; Gravalos, C; Guillen-Ponce, C; Sastre, J; Garcia-Foncillas, J.

Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?

CLINICAL & TRANSLATIONAL ONCOLOGY. 2016; 18(11): 1072-1081 Nº de citas: 10 [doi:10.1007/s12094-016-1499-8]

Aviles-Izquierdo, JA; Molina-Lopez, I; Rodriguez-Lomba, E; Marquez-Rodas, I; Suarez-Fernandez, R; Lazaro-Ochaita, P.

Who detects melanoma? Impact of detection patterns on characteristics and prognosis of patients with melanoma

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2016; 75(5): 967-974 Nº de citas: 57 [doi:10.1016/j.jaad.2016.07.009]

Obermannova, R; Van Cutsem, E; Yoshino, T; Bodoky, G; Prausova, J; Garcia-Carbonero, R; Ciuleanu, T; Alfonso, PG; Portnoy, D; Cohn, A; Yamazaki, K; Clingan, P; Lonardi, S; Kim, TW; Yang, L; Nasroulah, F; Tabernero, J.

Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression(aEuro)

ANNALS OF ONCOLOGY. 2016; 27(11): 2082-2089 Nº de citas: 59 [doi:10.1093/annonc/mdw402]

Pulford, DJ; Harter, P; Floquet, A; Barrett, C; Suh, DH; Friedlander, M; Arranz, JA; Hasegawa, K; Tada, H; Vuylsteke, P; Mirza, MR; Donadello, N; Scambia, G; Johnson, T; Cox, C; Chan, JK; Imhof, M; Herzog, TJ; Calvert, P; Wimberger, P; Berton-Rigaud, D; Lim, MC; Elser, G; Xu, CF; du Bois, A.

Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study

BMC MEDICAL ETHICS. 2016; 17: Nº de citas: 1 [doi:10.1186/s12910-016-0144-y]

Press, MF; Sauter, G; Buyse, M; Fourmanoir, H; Quinaux, E; Tsao-Wei, DD; Eiermann, W; Robert, N; Pienkowski, T; Crown, J; Martin, M; Valero, V; Mackey, JR; Bee, V; Ma, YL; Villalobos, I; Campeau, A; Mirlacher, M; Lindsay, MA; Slamon, DJ.

HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials

JOURNAL OF CLINICAL ONCOLOGY. 2016; 34(29): 3518 Nº de citas: 122 [doi:10.1200/JCO.2016.66.6693]

Awada, A; Cortes, J; Martin, M; Aftimos, P; Oliveira, M; Lopez-Tarruella, S; Espie, M; Lardelli, P; Extremera, S; Fernandez-Garcia, EM; Delaloge, S.

Phase 2 Study of Trabectedin in Patients With Hormone Receptor-Positive, HER-2-Negative, Advanced Breast Carcinoma According to Expression of Xeroderma Pigmentosum G Gene

CLINICAL BREAST CANCER. 2016; 16(5): 364-371 Nº de citas: 3 [doi:10.1016/j.clbc.2016.05.005]

Porta-Sales, J; Perez, C; Escobar, Y; Martinez, V.

Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2016; 18(9): 945-954 Nº de citas: 19 [doi:10.1007/s12094-015-1468-7]

Dalgleish, AG; Stebbing, J; Adamson, DJA; Arif, SS; Bidoli, P; Chang, D; Cheeseman, S; Diaz-Beveridge, R; Fernandez-Martos, C; Glynne-Jones, R; Granetto, C; Massuti, B; McAdam, K; McDermott, R; Martin, AJM; Papamichael, D; Pazo-Cid, R; Vieitez, JM; Zaniboni, A; Carroll, KJ; Wagle, S; Gaya, A; Mudan, SS.

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

BRITISH JOURNAL OF CANCER. 2016; 115(7): 789-796 Nº de citas: 48 [doi:10.1038/bjc.2016.271]

Jerusalem, G; Mariani, G; Ciruelos, EM; Martin, M; Tjan-Heijnen, VCG; Neven, P; Gavila, JG; Michelotti, A; Montemurro, F; Generali, D; Simoncini, E; Lang, I; Mardiak, J; Naume, B; Camozzi, M; Lorizzo, K; Bianchetti, S; Conte, P.

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

ANNALS OF ONCOLOGY. 2016; 27(9): 1719-1725 Nº de citas: 55 [doi:10.1093/annonc/mdw249]

Gonzalez-Rivera M; Picornell AC; Alvarez EL; Martin M.

A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol.

Jmir Research Protocols. 2016; 5(3): Nº de citas: 6 [doi:10.2196/resprot.6024]

Ramos-Medina, R; Moreno, F; Lopez-Tarruella, S; del Monte-Millan, M; Marquez-Rodas, I; Duran, E; Jerez, Y; Garcia-Saenz, JA; Ocana, I; Andres, S; Massarrah, T; Gonzalez-Rivera, M; Martin, M.

Review: circulating tumor cells in the practice of breast cancer oncology

CLINICAL & TRANSLATIONAL ONCOLOGY. 2016; 18(8): 749-759 Nº de citas: 5 [doi:10.1007/s12094-015-1460-2]

Martin, M; Lopez-Tarruella, S; Gilarranz, YJ.

Endocrine therapy for hormone treatment-naive advanced breast cancerf

BREAST. 2016; 28: 161-166 Nº de citas: 9 [doi:10.1016/j.breast.2016.05.015]

Garcia-Donas, J; Beuselinck, B; Inglada-Perez, L; Grana, O; Schoffski, P; Wozniak, A; Bechter, O; Apellaniz-Ruiz, M; Leandro-Garcia, LJ; Esteban, E; Castellano, DE; del Alba, AG; Climent, MA; Hernando, S; Arranz, JA; Morente, M; Pisano, DG; Robledo, M; Rodriguez-Antona, C.

Deep sequencing reveals microRNAs predictive of antiangiogenic drug response

Jci Insight. 2016; 1(10): Nº de citas: 40 [doi:10.1172/jci.insight.86051]